Vanguard Personalized Indexing Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
|
|||||
|
2025
Q1 | $935K | Sell |
|
|||||
|
2024
Q4 | $1.51M | Buy |
|
|||||
|
2024
Q3 | $1.07M | Buy |
|
|||||
|
2024
Q2 | $1.23M | Buy |
|
|||||
|
2024
Q1 | $1.21M | Sell |
|
|||||
|
2023
Q4 | $1.43M | Sell |
|
|||||
|
2023
Q3 | $1.47M | Buy |
|
|||||
|
2023
Q2 | $1.16M | Buy |
|
|||||
|
2023
Q1 | $1.23M | Buy |
|
|||||
|
2022
Q4 | $1.39M | Buy |
|
|||||
|
2022
Q3 | $1.19M | Sell |
|
|||||
|
2022
Q2 | $1.1M | Buy |
|
|||||
|
2022
Q1 | $1.05M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $320K | Sell |
|
|||||
|
2021
Q2 | $655K | Buy |
|